Precision Design of Cyclic Peptides using AlphaFold
PAPER This independent research study conducted a series of investigations to enhance the precision of cyclic peptide generation targeting the HIV gp120 trimer. The methods included proximity mapping to focus on the CD4 binding site, centroid distance penalization, generative loss tuning, and the development of custom generative functions. By synthesizing these findings, a novel methodology was implemented to generate candidate cyclic peptides of varying lengths. This process successfully produced cyclic peptides that resemble the crystal structure of CD4 attachment inhibitor (BMS-818251 molecule). This new methodology demonstrated improved control and precision in the generation of compounds, thereby enhancing the applicability of AlphaFold in the drug discovery process.
Jan 30, 2025
Precision Design of Cyclic Peptides using AlphaFold
Precision Design of Cyclic Peptides using AlphaFold
Nov 25, 2024
AlphaFold2 for Cyclic Peptide Design - A Deep-dive into Generative Drug Design (2/2)
Literature Review on the AF2 architecture and its use for cyclic peptide design
May 25, 2024
AlphaFold2 for Cyclic Peptide Design - A Deep-dive into Generative Drug Design (1/2)
Literature Review on the AF2 architecture and its use for cyclic peptide design
Jan 31, 2024
Insilico Medicine - Applying AI to Reduce Costs in Drug Discovery
Generative Drug-Discovery using Adversarial Auto-Generative Encoders
Sep 25, 2023